section name header

Pronunciation

me-TAX-a-lone

Classifications

Therapeutic Classification: skeletal muscle relaxants (centrally acting)

Indications

BEERS REMS


Action

  • Skeletal muscle relaxation, probably as a result of CNS depression.
Therapeutic effects:
  • Skeletal muscle relaxation.

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Unknown.

Metabolism/Excretion: Mostly metabolized by the liver; metabolites excreted in urine.

Half-Life: 2–3 hr.

Time/Action Profile

ROUTEONSETPEAKDURATION
PO1 hr2 hr4–6 hr

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GI: nausea, anorexia, dry mouth, GI upset, vomiting

GU: urinary retention

Neuro: dizziness, drowsiness, confusion, headache, irritability, nervousness

Misc: SEROTONIN SYNDROME

Interactions

Drug-drug:

Drug-Natural Products:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Skelaxin

Code

NDC Code